In general the current consensus is that the ΔNp63 proteins act as oncogenes by antagonizing p53 and through other alternate p53-indepedent mechanisms, while TAp63 isoforms are tumor and metastatic suppressors—an observation supported by mouse models [20, 28–31]. This evidence concerns the gene TP53 and neoplasm.